On February 3, 2021, Treatment Action Group, Médecins du Monde, hepCoalition, and the UNITE network presented a virtual policy dialogue among policymakers, global civil society organizations, and community leaders who share how COVID-19 has impacted global hepatitis C virus (HCV) elimination efforts. Following the International AIDS Society COVID-19 Prevention Conference, the virtual policy dialogue launches a policy brief that highlights how R&D and investments used for HCV have benefitted the COVID-19 response. We invite policymakers and community leaders to share their expertise, experiences on the ground, and initiatives that have sustained HCV responses during the pandemic.

Moderators:
Joelle Dountio, Treatment Action Group, and Samantha Hodgetts, Médecins du Monde

Panelists:
Bryn Gay – Treatment Action Group
Mariam Jashi – Member of Parliament; chairperson of the Education, Science and Culture Committee, and member of the Health and Social Affair Committees (Georgia)
Ketho Angami – ARK Foundation (India)
Ibtissame Azzaoui – Member of Parliament (Morocco)
Andrew Scheibe – TB HIV Care and University of Pretoria